J
James Robinson
Researcher at Nathan Kline Institute for Psychiatric Research
Publications - 44
Citations - 6384
James Robinson is an academic researcher from Nathan Kline Institute for Psychiatric Research. The author has contributed to research in topics: Substance abuse & Randomized controlled trial. The author has an hindex of 29, co-authored 43 publications receiving 5663 citations. Previous affiliations of James Robinson include Massachusetts Institute of Technology & New York University.
Papers
More filters
Journal ArticleDOI
Risperidone in Children with Autism and Serious Behavioral Problems
James T. McCracken,James J. McGough,Bhavik Shah,Pegeen Cronin,Daniel Hong,Michael G. Aman,L. Eugene Arnold,Ronald L. Lindsay,Patricia L. Nash,Jill A. Hollway,Christopher J. McDougle,David J. Posey,Naomi B. Swiezy,Arlene E. Kohn,Lawrence Scahill,Andrés Martin,Kathleen Koenig,Fred R. Volkmar,Deirdre H. Carroll,Allison Lancor,Allison Lancor,Elaine Tierney,Jaswinder K. Ghuman,N. González,Marco A. Grados,Benedetto Vitiello,Louise Ritz,Mark Davies,James Robinson,Donald J. McMahon +29 more
TL;DR: Risperidone was effective and well tolerated for the treatment of tantrums, aggression, or self-injurious behavior in children with autistic disorder and the benefit was maintained at six months.
Journal ArticleDOI
A high-resolution map of human evolutionary constraint using 29 mammals.
Kerstin Lindblad-Toh,Manuel Garber,Or Zuk,Michael F. Lin,Michael F. Lin,Brian J. Parker,Stefan Washietl,Pouya Kheradpour,Pouya Kheradpour,Jason Ernst,Jason Ernst,Gregory E. Jordan,Evan Mauceli,Lucas D. Ward,Lucas D. Ward,Craig B. Lowe,Craig B. Lowe,Craig B. Lowe,Alisha K. Holloway,Michele Clamp,Sante Gnerre,Jessica Alföldi,Kathryn Beal,Jean Chang,Hiram Clawson,James Cuff,Federica Di Palma,Stephen Fitzgerald,Paul Flicek,Mitchell Guttman,Melissa J. Hubisz,David B. Jaffe,Irwin Jungreis,W. James Kent,Dennis Kostka,Marcia Lara,André L. Martins,Tim Massingham,Ida Moltke,Brian J. Raney,Matthew D. Rasmussen,James Robinson,Alexander Stark,Albert J. Vilella,Jiayu Wen,Xiaohui Xie,Michael C. Zody,Kim C. Worley,Christie Kovar,Donna M. Muzny,Richard A. Gibbs,Wesley C. Warren,Elaine R. Mardis,George M. Weinstock,George M. Weinstock,Richard K. Wilson,Ewan Birney,Elliott H. Margulies,Javier Herrero,Eric D. Green,David Haussler,David Haussler,Adam Siepel,Nick Goldman,Katherine S. Pollard,Jakob Skou Pedersen,Jakob Skou Pedersen,Eric S. Lander,Manolis Kellis,Manolis Kellis +69 more
TL;DR: The comparison of related genomes has emerged as a powerful lens for genome interpretation and sequencing and comparative analysis of 29 eutherian genomes confirm that at least 5.5% of the human genome has undergone purifying selection, and locate constrained elements covering ∼4.2%" of the genome.
Journal ArticleDOI
Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity
David J. Posey,David J. Posey,Michael G. Aman,L. Eugene Arnold,Yaser Ramadan,Andrea N. Witwer,Ronald L. Lindsay,Christopher J. McDougle,Naomi B. Swiezy,Arlene E. Kohn,James T. McCracken,Bhavik Shah,Pegeen Cronin,James J. McGough,Lisa Sea Yun Lee,Lawrence Scahill,Andrés Martin,Kathleen Koenig,Deirdre H. Carroll,Christopher Young,Allison Lancor,Elaine Tierney,Jaswinder K. Ghuman,N. González,Marco A. Grados,Benedetto Vitiello,Louise Ritz,Shirley Chuang,Mark Davies,James Robinson,Donald J. McMahon +30 more
TL;DR: Methylphenidate was often efficacious in treating hyperactivity associated with pervasive developmental disorders, but the magnitude of response was less than that seen in typically developing children with attention-deficit/hyperactivity disorder.
Journal ArticleDOI
Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression
Christoph U. Correll,Britta Galling,Britta Galling,Aditya Pawar,Anastasia Krivko,Chiara Bonetto,Mirella Ruggeri,Thomas J. Craig,Merete Nordentoft,Merete Nordentoft,Vinod H. Srihari,Sinan Guloksuz,Sinan Guloksuz,Christy L.M. Hui,Eric Y.H. Chen,Marcelo Valencia,Francisco Juárez,Delbert G. Robinson,Delbert G. Robinson,Nina R. Schooler,Mary F. Brunette,Kim T. Mueser,Robert A. Rosenheck,Patricia Marcy,Jean Addington,Sue E. Estroff,James Robinson,David L. Penn,Joanne B. Severe,John M. Kane,John M. Kane +30 more
TL;DR: In this paper, the authors compared early intervention services (EIS) with treatment as usual (TAU) for early-phase psychosis and found that EIS was associated with better outcomes than TAU at the end of treatment for all 13 meta-analyzable outcomes.
Journal ArticleDOI
The Pediatric Anxiety Rating Scale (PARS): Development and Psychometric Properties
Ma Riddle,Gs Ginsburg,Jt Walkup,Mj Labellarte,Ds Pine,Mark Davies,L. Greenhill,Michael Sweeney,Rachel G. Klein,Howard B. Abikoff,Sabine Hack,Brian Klee,Lindsey Bergman,John S. March,Scott N. Compton,James Robinson,Thomas O’hara,Sherryl Baker,Benedetto Vitiello,Louise Ritz,Margaret Roper +20 more
TL;DR: The PARS is a useful clinician-rated instrument for assessing pediatric anxiety symptoms, severity, and impairment, particularly in treatment studies and further study of the psychometric properties is warranted.